cyclosporine and ibuprofen

Cyclosporine causes afferent arteriolar vasoconstriction in the kidney. Non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen inhibit renal prostaglandin synthesis, which leads to further reduction in renal blood flow and glomerular filtration rate. The combined effect is additive nephrotoxicity. Additionally, ibuprofen may interfere with the renal elimination of cyclosporine or its metabolites, although the exact contribution is unclear.

Co-administration can result in a significant decline in renal function, leading to acute kidney injury, especially in patients with pre-existing renal impairment, dehydration, or concurrent use of other nephrotoxic agents. Cyclosporine blood levels may also rise, increasing the risk of cyclosporine-related toxicity, including hypertension and neurotoxicity.

Avoid concomitant use if possible. If necessary, use the lowest effective dose of ibuprofen for the shortest duration. Monitor serum creatinine, blood urea nitrogen, and cyclosporine trough levels frequently (e.g., every 2-4 weeks) during therapy and for several weeks after discontinuation. Ensure adequate hydration and consider alternative analgesics such as paracetamol for pain relief.

This interaction is well documented in clinical practice and case reports. Studies have shown additive nephrotoxicity with NSAIDs and cyclosporine, and monitoring of renal function and cyclosporine levels is widely recommended. However, the magnitude of the effect varies between individuals and depends on the dose and duration of NSAID therapy.